News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Busch Andreas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2022 |
4
| Busch Andreas (Chief Innovation Officer) has filed a Form 4 on Absci Corp|
Txns:
| Granted 2,000,009 options to buy
@ $2.97, valued at
$5.9M
|
|
| 06/10/2022 |
4
| Busch Andreas (Director) has filed a Form 4 on Absci Corp|
Txns:
| Granted 4,783 options to buy
@ $3.39, valued at
$16.2k
|
|
| 03/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/24/2022 |
4
| Busch Andreas (Chief Scientific Officer) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.21, valued at
$163.4k
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2020 |
4
| Busch Andreas (Chief Innovation Officer) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Bought 125,000 shares
@ $2.53, valued at
$316.3k
|
|
| 11/06/2020 |
4
| Busch Andreas (Chief Innovation Officer) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $2.48, valued at
$186k
|
|
| 11/26/2019 |
4
| Busch Andreas (Chief Innovation Officer) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $2.01, valued at
$150.8k
|
|
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2019 |
4
| Busch Andreas (Chief Innovation Officer) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $15.4, valued at
$4.6M
|
|
| 05/01/2019 |
3
| Busch Andreas (Chief Innovation Officer) has filed a Form 3 on Cyclerion Therapeutics, Inc. |
|
|